Skip to Main Content
Contribute Try STAT+ Today

Scott Gottlieb is stepping down as leader of the FDA — and many in health and medicine quickly turned to Twitter to express their displeasure.

Gottlieb, who has served as the commissioner of the Food and Drug Administration since May 2017, announced on Tuesday that he plans to leave his post in one month. During his tenure, the FDA broke annual records for generic drug approvals, cracked down on unproven stem cell treatments, and took new steps to curb youth e-cigarette use.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.